The Technical AnalystExchange: OSE Sector: Biotechnology Industry: Biotechnology
Arcticzymes Technologies Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: BUY (auto-tracking)
-2.82% NOK25.80
Europe/Oslo / 25 apr 2024 @ 16:28
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 1 312.48 mill |
| EPS: | 0.340 |
| P/E: | 75.88 |
| Earnings Date: | May 08, 2024 |
| SharesOutstanding: | 50.87 mill |
| Avg Daily Volume: | 0.0348 mill |
| RATING 2024-04-25 |
|---|
| A+ |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Neutral | |
| Return On Asset: | Buy | |
| DE: | Neutral | |
| P/E: | Strong Buy | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 5.18x |
| Company: PE 75.88 | sector: PE 14.65 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE 75.88 | industry: PE -0.482 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
NOK19.22 (-25.49%) NOK-6.58 |
| Date: 2024-04-25 |
| Expected Trading Range (DAY) |
|---|
|
NOK 24.62 - 26.98 ( +/- 4.56%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | NOK25.80 (-2.82% ) |
| Volume | 0.280 mill |
| Avg. Vol. | 0.0348 mill |
| % of Avg. Vol | 805.92 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For AZT.OL
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % | Feb 8 - 15:24 | buy | NOK29.50 | N/A | Active |
|---|
AZT.OL
ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, In vitro diagnostics, and biomanufacturing. It offers salt active nuclease for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; shrimp alkaline phosphatase and derived kits for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays; double-strand specific DNases and derived kits for the removal of double stranded DNA; polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining DNA /RNA fragments. It operates in Norway, Germany, Lithuania, Italy, other countries in Europe, the United States, and internationally. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was incorporated in 1990 and is headquartered in Tromsø, Norway.